Mayo Clinic researchers reported a strong hint that blood plasma from COVID-19 survivors helps other patients recover, but it’s not proof and some experts worry if, amid clamor for the treatment, they’ll ever get a clear answer. The study involved over 35,000 patients that received convalescent plasma therapy. Those patientsContinue Reading

The National Institutes of Health has announced that clinical trials of antibodies are now starting. These trials are to prevent infection instead of treating coronavirus infections. Two Phase 3, randomized, placebo-controlled, double-blind clinical trials testing whether experimental monoclonal antibodies (mAbs) can prevent infection by SARS-CoV-2 coronavirus are now enrolling healthyContinue Reading

Preliminary research by Mayo Clinic shows that high-dose plasma therapy is correlated with fewer deaths in patients with severe COVID-19. A 10 percentage point difference in deaths was found when comparing hospitalized COVID-19 patients who received donor plasma with high concentrations of virus-fighting antibodies compared with those who received lowerContinue Reading

This week on Podcast-19, FiveThirtyEight talks about lab-grown antibodies, called monoclonal antibodies, that could temporarily protect people from COVID-19. How soon might they be available for the public? This podcast episode also discusses Dexamethasone, a steroid drug that appears promising for COVID-19 patients.Continue Reading